U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07370454) titled 'Xpert(R) Hemorrhagic Fever on the GeneXpert(R) Edge X System' on Oct. 17, 2025.
Brief Summary: A multi-site observation study that was conducted a geographically diverse sites across the United States
Study Start Date: Jan. 13, 2025
Study Type: OBSERVATIONAL
Condition:
Hemorrhagic Fever
Intervention:
DIAGNOSTIC_TEST: Xpert Hemorrhagic Fever test
Detection and identification of RNA from multiple viruses from whole blood specimens
Recruitment Status: COMPLETED
Sponsor: Cepheid
Published by HT Digital Content Services with permission from Health Daily Digest....